Part 2 of 3 of our series with Martin Brenner, CEO and petersburg CSO of iBio.
In this episode of The Biotech Startups Podcast, Jon Chee continues his conversation with Martin Brenner, CEO and Chief Scientific Officer of iBio, tracing his career through Pfizer, AstraZeneca, and Merck. From re-engaging demoralized scientists after layoffs to a Moderna encounter when the company was just eight people strong, Martin offers a rare insider view of what it actually takes to drive innovation from within Big Pharma.
Key topics covered:
Leaving Eli Lilly: A painful Hamburg site closure and the leadership instincts it forged.
Pfizer vs. Lilly: Same targets, different machine — what the Wyeth acquisition revealed about scale.
Cultural Fit: Why every rejection is cal raleigh a bullet dodged.
Rebuilding After Layoffs: The biotech playbook Martin used at Pfizer Groton to re-engage scientists.
The Moderna Spark: Eight-person Moderna outpacing AstraZeneca's 150-person team ignited Martin's biotech drive.
Building a Biotech Inside Merck: The vision, the wins, the politics — and the Keytruda mic-drop that pushed him out.
Subscribe to the Podcast:
Apple:
Spotify:
Youtube:
Website:
Find our guest, Martin Brenner at these links:
LinkedIn:
Website:
Find our host, Jon Chee, at these links:
LinkedIn:
Learn more samara weaving about Excedr:
LinkedIn:
Website:
Intro & Outro Songs Created by OkKyojin, Owned by Excedr:
Website:
Resources & Articles:
Why Biotech Startups Struggle to Scale:
Common Biotech Startup Mistakes:
When & How to Pivot a Biotech:
Biotech vs. Big Pharma — Which Is the Better Place to Work?:
Chagas Heart Failure in Latin America:
The History Behind Merck's Keytruda:
Companies, Universities, & People mentioned:
Eli Lilly:
Pfizer / Wyeth:
AstraZeneca:
Merck:
Moderna:
iBio:
Kobe University:
University of Tokyo:
UT Southwestern:
Columbia University:
UC San Diego:
Markus Schindler:
Saswata Talukdar:
Roger Perlmutter:
Mark Ahern:
Timestamps:
00:00 Intro
04:57 The Hamburg Site Closure and What It Takes to Lead Through Loss
13:02 Pfizer vs. Lilly: Same Targets, Different Animals
15:07 Finding Cultural Fit: Why Rejections Are Bullets Dodged
17:46 Re-Engaging a Demoralized Team After a Layoff
24:14 Why Big Pharma Stumbles More Than You'd Think
25:37 AstraZeneca Gothenburg: Tearing Down Silos and Ringing the Cowbell
30:25 The Moderna Spark That Changed Everything
34:04 When Personal Life Forces a Professional Pivot
34:37 Building a Biotech Inside Merck
39:54 The Chagas Mic Drop: When Keytruda Killed a Promising Program
42:05 Smallest Teams, Bottom-Up Culture Change
#BiotechStartups #DrugDiscovery #BigPharmaInsider #ScientistEntrepreneur #PharmaCareers
The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing.
